Mitochondrial metabolism as a potential therapeutic target in myeloid leukaemia

While the understanding of the genomic aberrations that underpin chronic and acute myeloid leukaemia (CML and AML) has allowed the development of therapies for these diseases, limitations remain. These become apparent when looking at the frequency of treatment resistance leading to disease relapse i...

Descripción completa

Detalles Bibliográficos
Autores principales: de Beauchamp, Lucie, Himonas, Ekaterini, Helgason, G. Vignir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727299/
https://www.ncbi.nlm.nih.gov/pubmed/34561557
http://dx.doi.org/10.1038/s41375-021-01416-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8727299/
https://www.ncbi.nlm.nih.gov/pubmed/34561557
http://dx.doi.org/10.1038/s41375-021-01416-w

Ejemplares similares